Ahrendsen Jared T, Moore Justin M, Varma Hemant
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, Massachusetts, United States.
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, Massachusetts, United States.
Surg Neurol Int. 2021 Feb 17;12:60. doi: 10.25259/SNI_904_2020. eCollection 2021.
The differential diagnosis for mass forming lesions of the middle ear is broad. While uncommon, neuroglial heterotopias can occur in the middle ear and can be a source of diagnostic confusion for clinician, radiologist, and pathologist alike.
We identified three cases of neuroglial heterotopia of the middle ear in our institutional archives from 2000 to 2020 and performed extensive histological and immunohistochemical characterization of the three lesions. We conducted a systematic literature review to identify 27 cases published in the English literature between the years 1980 and 2020. Only cases with histological verification of neuroglial heterotopia specifically involving the middle ear were included. We compiled the clinical, radiological, and histopathological findings for all 30 cases.
Patients most frequently presented with chronic otitis media (40%), hearing loss (40%), or prior history of ear surgery or trauma (13%). The median age at surgery was 49 years with a male predominance (M:F 2:1); however, a bimodal age distribution was noted with an earlier onset (11 years or younger) in a subset of patients. Immunohistochemical characterization showed mature neuronal and reactive glial populations with low Ki67 proliferation index and chronic inflammatory infiltrates. There was no neuronal dysplasia or glial atypia, consistent with benign, nonneoplastic, mature glioneuronal tissue.
Immunohistochemical characterization of these lesions and clinical follow-up confirms their benign natural history. Potential etiologies include developmental misplacement, trauma, and chronic inflammation/ reactive changes resulting in sequestered encephalocele.
中耳肿块形成性病变的鉴别诊断范围广泛。神经胶质异位虽然不常见,但可发生于中耳,可能给临床医生、放射科医生和病理科医生带来诊断困惑。
我们在机构档案中识别出2000年至2020年间的3例中耳神经胶质异位病例,并对这3个病变进行了广泛的组织学和免疫组化特征分析。我们进行了系统的文献综述,以识别1980年至2020年间英文文献中发表的27例病例。仅纳入经组织学证实为中耳特异性神经胶质异位的病例。我们汇总了所有30例病例的临床、放射学和组织病理学检查结果。
患者最常见的表现为慢性中耳炎(40%)、听力损失(40%)或既往耳部手术或外伤史(13%)。手术时的中位年龄为49岁,男性占优势(男:女为2:1);然而,注意到年龄分布呈双峰型,部分患者发病较早(11岁或以下)。免疫组化特征显示为成熟的神经元和反应性胶质细胞群体,Ki67增殖指数低,伴有慢性炎症浸润。没有神经元发育异常或胶质细胞异型性,符合良性、非肿瘤性、成熟的神经胶质神经元组织。
这些病变的免疫组化特征及临床随访证实了其良性的自然病程。潜在病因包括发育错位、创伤以及导致脑膨出隔离的慢性炎症/反应性改变。